Genertec Universal Medical Group Company Limited

SEHK:2666 Rapport sur les actions

Capitalisation boursière : HK$8.8b

Genertec Universal Medical Group Résultats passés

Passé contrôle des critères 5/6

Genertec Universal Medical Group a connu une croissance annuelle moyenne de ses bénéfices de 7.2%, tandis que le secteur Diversified Financial a vu ses bénéfices augmenter de en hausse à 7.7% par an. Les revenus ont augmenté de en hausse à un taux moyen de 16.7% par an. Le rendement des capitaux propres de Genertec Universal Medical Group est 10.1% et ses marges nettes sont de 15.6%.

Informations clés

7.2%

Taux de croissance des bénéfices

4.6%

Taux de croissance du BPA

Diversified Financial Croissance de l'industrie10.8%
Taux de croissance des recettes16.7%
Rendement des fonds propres10.1%
Marge nette15.6%
Dernière mise à jour des bénéfices30 Jun 2024

Mises à jour récentes des performances passées

Recent updates

Earnings Working Against Genertec Universal Medical Group Company Limited's (HKG:2666) Share Price

Oct 09
Earnings Working Against Genertec Universal Medical Group Company Limited's (HKG:2666) Share Price

Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

May 22
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Genertec Universal Medical Group Company Limited's (HKG:2666) Price Is Right But Growth Is Lacking

May 10
Genertec Universal Medical Group Company Limited's (HKG:2666) Price Is Right But Growth Is Lacking

Why Investors Shouldn't Be Surprised By Genertec Universal Medical Group Company Limited's (HKG:2666) Low P/E

Feb 05
Why Investors Shouldn't Be Surprised By Genertec Universal Medical Group Company Limited's (HKG:2666) Low P/E

Genertec Universal Medical Group (HKG:2666) Is Reducing Its Dividend To CN¥0.34

Jun 08
Genertec Universal Medical Group (HKG:2666) Is Reducing Its Dividend To CN¥0.34

Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 08
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 31
Genertec Universal Medical Group's (HKG:2666) Shareholders Will Receive A Bigger Dividend Than Last Year

Should You Be Adding Genertec Universal Medical Group (HKG:2666) To Your Watchlist Today?

Aug 20
Should You Be Adding Genertec Universal Medical Group (HKG:2666) To Your Watchlist Today?

Here's Why We Think Genertec Universal Medical Group (HKG:2666) Is Well Worth Watching

Apr 19
Here's Why We Think Genertec Universal Medical Group (HKG:2666) Is Well Worth Watching

Shareholders Of Genertec Universal Medical Group (HKG:2666) Must Be Happy With Their 34% Return

Mar 10
Shareholders Of Genertec Universal Medical Group (HKG:2666) Must Be Happy With Their 34% Return

Is Genertec Universal Medical Group Company Limited (HKG:2666) Trading At A 48% Discount?

Feb 19
Is Genertec Universal Medical Group Company Limited (HKG:2666) Trading At A 48% Discount?

Did Genertec Universal Medical Group Company Limited (HKG:2666) Insiders Buy Up More Shares?

Feb 01
Did Genertec Universal Medical Group Company Limited (HKG:2666) Insiders Buy Up More Shares?

The Case For Genertec Universal Medical Group Company Limited (HKG:2666): Could It Be A Nice Addition To Your Dividend Portfolio?

Jan 11
The Case For Genertec Universal Medical Group Company Limited (HKG:2666): Could It Be A Nice Addition To Your Dividend Portfolio?

What Kind Of Investors Own Most Of Genertec Universal Medical Group Company Limited (HKG:2666)?

Dec 21
What Kind Of Investors Own Most Of Genertec Universal Medical Group Company Limited (HKG:2666)?

Reflecting on Genertec Universal Medical Group's (HKG:2666) Share Price Returns Over The Last Three Years

Nov 30
Reflecting on Genertec Universal Medical Group's (HKG:2666) Share Price Returns Over The Last Three Years

Ventilation des recettes et des dépenses

Comment Genertec Universal Medical Group gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

SEHK:2666 Recettes, dépenses et bénéfices (CNY Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Jun 2413,2032,0611,6550
31 Mar 2413,3112,0411,6100
31 Dec 2313,4192,0211,5660
30 Sep 2313,1611,9601,4860
30 Jun 2312,7971,8961,3970
31 Mar 2312,2641,8921,3760
31 Dec 2211,7301,8881,3560
30 Sep 2211,0181,8821,2920
30 Jun 2210,3051,8751,2280
31 Mar 229,9361,8551,2150
31 Dec 219,5671,8351,2020
30 Sep 219,3711,8701,2000
30 Jun 219,1751,9041,1980
31 Mar 218,7091,7761,0960
31 Dec 208,2431,6489940
30 Sep 207,8431,5599610
30 Jun 207,4441,4709280
31 Mar 207,0951,4798870
31 Dec 196,7471,4898460
30 Sep 196,0711,4597760
30 Jun 195,3951,4297070
31 Mar 194,8451,3906690
31 Dec 184,2951,3526320
30 Sep 184,0801,3295810
30 Jun 183,8651,3055300
31 Mar 183,6451,2275270
31 Dec 173,4241,1495240
30 Sep 173,2671,1055560
30 Jun 173,1111,0625880
31 Mar 172,9109675710
31 Dec 162,7098725540
30 Sep 162,5878255400
30 Jun 162,4647785250
31 Mar 162,3307184930
31 Dec 152,1956594600
30 Sep 152,0316054100
30 Jun 151,8665513590
31 Mar 151,7115043380
31 Dec 141,5574573170
31 Dec 139843132610

Des revenus de qualité: 2666 a des bénéfices de haute qualité.

Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de 2666 sont plus élevées que l'année dernière 2666. (15.6%) sont plus élevées que l'année dernière (14.8%).


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: Les bénéfices de 2666 ont augmenté de 7.2% par an au cours des 5 dernières années.

Accélération de la croissance: La croissance des bénéfices de 2666 au cours de l'année écoulée ( 8.7% ) dépasse sa moyenne sur 5 ans ( 7.2% par an).

Bénéfices par rapport au secteur d'activité: La croissance des bénéfices 2666 au cours de l'année écoulée ( 8.7% ) a dépassé celle du secteur Diversified Financial -3.1%.


Rendement des fonds propres

ROE élevé: Le retour sur capitaux propres de 2666 ( 10.1% ) est considéré comme faible.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé